How should the oral glucose challenge test (OGCT) be performed and interpreted in a pregnant woman at 24–28 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

OGCT in Pregnancy: Performance and Interpretation at 24-28 Weeks

Screen all pregnant women at 24-28 weeks gestation using either a one-step 75-g OGTT or a two-step approach starting with a 50-g glucose challenge test, with the one-step method preferred based on the most recent ADA guidelines to optimize maternal and fetal outcomes. 1

Screening Strategy Options

You have two validated approaches, both supported by current guidelines 2, 1:

One-Step Strategy (IADPSG Criteria - ADA Preferred)

Procedure:

  • Administer 75-g oral glucose load after overnight fast (minimum 8 hours)
  • Perform in the morning
  • Measure plasma glucose at: fasting, 1 hour, and 2 hours
  • Timing: 24-28 weeks gestation 2, 1

Diagnostic Thresholds - GDM diagnosed if ANY ONE value meets or exceeds:

  • Fasting: ≥92 mg/dL (5.1 mmol/L)
  • 1 hour: ≥180 mg/dL (10.0 mmol/L)
  • 2 hour: ≥153 mg/dL (8.5 mmol/L) 2, 1

Key advantage: Only one abnormal value needed for diagnosis, based on HAPO study showing continuous risk increase for adverse outcomes (preeclampsia, macrosomia, shoulder dystocia) even at glucose levels previously considered normal 2, 1.

Two-Step Strategy (Traditional Approach)

Step 1 - Screening:

  • 50-g glucose load (non-fasting acceptable)
  • Measure plasma glucose at 1 hour
  • Threshold options: ≥130,135, or 140 mg/dL (7.2,7.5, or 7.8 mmol/L)
  • If positive, proceed to Step 2 2, 1

Step 2 - Diagnostic:

  • 100-g OGTT after overnight fast
  • Measure plasma glucose at: fasting, 1,2, and 3 hours

Carpenter-Coustan Criteria - GDM diagnosed if AT LEAST TWO values meet or exceed:

  • Fasting: ≥95 mg/dL (5.3 mmol/L)
  • 1 hour: ≥180 mg/dL (10.0 mmol/L)
  • 2 hour: ≥155 mg/dL (8.6 mmol/L)
  • 3 hour: ≥140 mg/dL (7.8 mmol/L) 2, 1

Note: ACOG accepts one elevated value for diagnosis, though traditional criteria require two 2.

Critical Clinical Context

Why 24-28 weeks matters: The HAPO study with >23,000 pregnant women demonstrated that maternal glycemia at this gestational window directly correlates with adverse outcomes in a continuous fashion—no safe threshold exists 2, 1. This timing captures physiologic insulin resistance that peaks in the third trimester while allowing intervention before delivery.

Diagnostic criteria differences: The one-step approach will identify 15-20% of pregnancies as GDM versus 5-6% with older criteria 2. This isn't overdiagnosis—intervention trials show that treating these "milder" cases reduces large-for-gestational-age births and preeclampsia, with 80-90% manageable by lifestyle alone 3.

Common Pitfalls to Avoid

Do not use A1C for GDM screening at 24-28 weeks: Pregnancy increases red blood cell turnover, making A1C unreliable for diagnosis at this stage 1. Reserve A1C for early pregnancy screening for pre-existing diabetes only.

Do not use casual/random glucose alone: Research shows that 71.7% of women with GDM had casual glucose <100 mg/dL, meaning casual glucose screening misses the majority of cases 4. The structured OGTT is essential.

Do not screen before 24 weeks using standard GDM criteria: These diagnostic thresholds were derived from 24-28 week data and lack validation for earlier screening 2. If early screening is indicated (high-risk patients), use standard non-pregnancy diabetes criteria to identify pre-existing diabetes, then rescreen at 24-28 weeks if negative.

Threshold selection for 50-g test: Using 140 mg/dL threshold captures 70-88% of GDM cases; lowering to 130 mg/dL increases sensitivity to 88-99% but requires more diagnostic OGTTs 5. Consider 130 mg/dL in high-risk populations (Hispanic, Native American, South/East Asian, African American, Pacific Islander descent) 6.

Post-Diagnosis Implications

Women diagnosed with GDM face substantially increased lifetime diabetes risk and require:

  • Postpartum screening at 4-12 weeks using 75-g OGTT with non-pregnancy criteria
  • Lifelong screening every 1-3 years
  • Intensive lifestyle intervention or metformin if prediabetes develops 2, 3

The diagnosis carries prognostic weight beyond the current pregnancy—it identifies underlying β-cell dysfunction that predates pregnancy and persists afterward 3.

References

Related Questions

What glucose load (grams) and gestational age are recommended for performing an oral glucose tolerance test (OGTT) in pregnancy?
What is the immediate management of acute hypoglycemia in a 55-year-old man with type 2 diabetes mellitus on insulin who skipped breakfast and presents with a capillary glucose of 42 mg/dL, pale, sweaty, tachycardic, and confused?
During a 100‑gram oral glucose tolerance test, my 180‑minute glucose level was 39 mg/dL, yet my home glucose measurements are within normal limits—what does this finding indicate and how should it be managed?
What is the clinical significance of a +1 glucose result on a urine dipstick and how should it be evaluated?
In a 23‑year‑old woman who had a single unprovoked tonic‑clonic‑appearing event two months ago associated with documented hypoglycemia (capillary glucose 3.3 mmol/L) and now experiences brief conscious auras with head tremor and visual disturbances, with normal neurological examination and routine laboratory tests, what specific history questions should be asked, which investigations (e.g., EEG, brain MRI, metabolic panel, oral glucose tolerance test, continuous glucose monitoring) are indicated, how should the hypoglycemia be managed, and how should the overall work‑up be interpreted and concluded?
Why does cholestasis occur in hepatitis A?
In a patient with thrombocytopenia, large platelets and clumping on peripheral smear, normal LDH and normal serum vitamin B12, what is the next step in evaluation?
How should an 8‑month‑old infant presenting to the emergency department with acute cough, drooling, afebrile status, no pharyngitis, bilateral rhonchi on chest examination, oxygen saturation of 95%, and a soft, non‑tender abdomen be managed?
What precautions are needed when starting semaglutide in a patient taking acenocoumarol (Acitrom)?
If a repeat sample also shows thrombocytopenia, what diagnostic tests should be performed?
Is antiviral therapy indicated for hepatitis A infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.